Related Experiment Video
Updated: Jun 6, 2026

Christopher Hughes: An in vitro model for the Study of Angiogenesis (Interview)
Published on: April 28, 2007
Hughes syndrome (the antiphospholipid syndrome): a disease of our time
1The London Lupus Centre, London Bridge Hospital, London, UK. graham.hughes@hcaconsultant.co.uk
Abstract:
A pro-thrombotic condition was described in 1983 which was characterised by the presence of circulating antiphospholipid antibodies, as well as peripheral thrombosis (e.g. DVT), a tendency to internal organ involvement, repeated miscarriage, and, occasionally, thrombocytopenia (aPL) (Hughes, Br Med J 287:1088-1089, 1983). Previously, there had been a number of observations, mainly in patients with lupus having "false positive" tests for syphilis, miscarriage and circulating lupus anticoagulants. The description in 1983 had three notable features (a) a detailed comprehensive clinical picture of the syndrome; (b) this description differed from other coagulopathies in showing a propensity for arterial thrombosis (e.g. stroke and heart attack); and (c) this was a syndrome quite independent from lupus. There are indications that the primary antiphospholipid syndrome will turn out to be more common than lupus, though this could still be a reflection of referral practice.
Related Concept Videos
Huntington Disease l: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hypersensitivity Reactions: Immune-Complex Reactions
Humoral Immune Responses
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
